Filipe V - Search Results

1

Asymmetrical flow field-flow fractionation method for the analysis of submicron protein aggregates.

Hawe A, Romeijn S, Filipe V, Jiskoot W. Hawe A, et al. Among authors: filipe v. J Pharm Sci. 2012 Nov;101(11):4129-39. doi: 10.1002/jps.23298. Epub 2012 Aug 21. J Pharm Sci. 2012. PMID: 22911663

2

Fluorescent molecular rotors as dyes to characterize polysorbate-containing IgG formulations.

Hawe A, Filipe V, Jiskoot W. Hawe A, et al. Among authors: filipe v. Pharm Res. 2010 Feb;27(2):314-26. doi: 10.1007/s11095-009-0020-2. Epub 2009 Dec 30. Pharm Res. 2010. PMID: 20041280 Free PMC article.

3

Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates.

Filipe V, Hawe A, Jiskoot W. Filipe V, et al. Pharm Res. 2010 May;27(5):796-810. doi: 10.1007/s11095-010-0073-2. Epub 2010 Mar 4. Pharm Res. 2010. PMID: 20204471 Free PMC article.

4

Mass spectrometric analysis of intact human monoclonal antibody aggregates fractionated by size-exclusion chromatography.

Kükrer B, Filipe V, van Duijn E, Kasper PT, Vreeken RJ, Heck AJ, Jiskoot W. Kükrer B, et al. Among authors: filipe v. Pharm Res. 2010 Oct;27(10):2197-204. doi: 10.1007/s11095-010-0224-5. Epub 2010 Aug 3. Pharm Res. 2010. PMID: 20680668 Free PMC article.

5

Fluorescence single particle tracking for the characterization of submicron protein aggregates in biological fluids and complex formulations.

Filipe V, Poole R, Kutscher M, Forier K, Braeckmans K, Jiskoot W. Filipe V, et al. Pharm Res. 2011 May;28(5):1112-20. doi: 10.1007/s11095-011-0374-0. Epub 2011 Feb 5. Pharm Res. 2011. PMID: 21298328 Free PMC article.

6

Detection and characterization of subvisible aggregates of monoclonal IgG in serum.

Filipe V, Poole R, Oladunjoye O, Braeckmans K, Jiskoot W. Filipe V, et al. Pharm Res. 2012 Aug;29(8):2202-12. doi: 10.1007/s11095-012-0749-x. Epub 2012 Mar 31. Pharm Res. 2012. PMID: 22467219 Free PMC article.

7

Transient molten globules and metastable aggregates induced by brief exposure of a monoclonal IgG to low pH.

Filipe V, Kükrer B, Hawe A, Jiskoot W. Filipe V, et al. J Pharm Sci. 2012 Jul;101(7):2327-39. doi: 10.1002/jps.23157. Epub 2012 Apr 19. J Pharm Sci. 2012. PMID: 22517069

8

Stability of rituximab in freeze-dried formulations containing trehalose or melibiose under different relative humidity atmospheres.

Heljo VP, Filipe V, Romeijn S, Jiskoot W, Juppo AM. Heljo VP, et al. Among authors: filipe v. J Pharm Sci. 2013 Feb;102(2):401-14. doi: 10.1002/jps.23392. Epub 2012 Nov 28. J Pharm Sci. 2013. PMID: 23192744

9

In vivo fluorescence imaging of IgG1 aggregates after subcutaneous and intravenous injection in mice.

Filipe V, Que I, Carpenter JF, Löwik C, Jiskoot W. Filipe V, et al. Pharm Res. 2014 Jan;31(1):216-27. doi: 10.1007/s11095-013-1154-9. Epub 2013 Aug 15. Pharm Res. 2014. PMID: 23949250

10

Stress Factors in Protein Drug Product Manufacturing and Their Impact on Product Quality.

Das TK, Sreedhara A, Colandene JD, Chou DK, Filipe V, Grapentin C, Searles J, Christian TR, Narhi LO, Jiskoot W. Das TK, et al. Among authors: filipe v. J Pharm Sci. 2022 Apr;111(4):868-886. doi: 10.1016/j.xphs.2021.09.030. Epub 2021 Sep 24. J Pharm Sci. 2022. PMID: 34563537

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters